➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Harvard Business School
Merck
Medtronic
Colorcon

Last Updated: May 6, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for endoxan

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for endoxan?

endoxan is an investigational drug.

There have been 67 clinical trials for endoxan. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2004.

The most common disease conditions in clinical trials are Lymphoma, Leukemia, and Lymphoma, Non-Hodgkin. The leading clinical trial sponsors are National Cancer Institute (NCI), Sidney Kimmel Cancer Center at Thomas Jefferson University, and City of Hope Medical Center.

Recent Clinical Trials for endoxan
TitleSponsorPhase
A Study of a New Way to Treat Children With a Brain Tumor Called NGGCTChildren's Oncology GroupPhase 2
Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal AdenocarcinomaLonza Walkersville, Inc.Phase 1
Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal AdenocarcinomaFred Hutchinson Cancer Research CenterPhase 1

See all endoxan clinical trials

Clinical Trial Summary for endoxan

Top disease conditions for endoxan
Top clinical trial sponsors for endoxan

See all endoxan clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
AstraZeneca
Medtronic
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.